the frequent occurrence of anaphylactic type deaths in young ( 1 month old ) animals receiving more than six weekly injections of partially purified homologous ( rat ) monoclonal antibodies to rat class ii gene products underscores the potential risks of this type of immunotherapy .
C0034693
rat
C1335665
rat